AMG 701
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMG 701, covering 2024-09-23 to 2025-10-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1]